The battle against COVID-19 vaccine hesitancy—an issue for nearly a quarter of Americans recently polled—can be won if messages promoting vaccination suggest most people will take it and political motivations did not rush its development, research at Georgia State University has found. Those who were introduced to messages suggesting most people would not take the […]
Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR would become a breakthrough targeted therapy for children and adults suffering relapses of acute myeloid leukemia (AML) and other cancers where mTOR activity is abnormally high. However, numerous […]
